Holen Sie sich die Stockscreener-App
2.64
1.49%
-0.04
Handel nachbörslich:
2.67
0.03
+1.14%
Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten
Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World
European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - GlobeNewswire Inc.
Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World
DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World
Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World
Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World
TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World
Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX
NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel By Investing.com - Investing.com South Africa
Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens By Stocktwits - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel - Investing.com
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocksregister
Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa
Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com
AUTL’s Market Whiplash: -44.26% YTD Decline, -21.08% Plunge in 30 Days - investchronicle.com
There is no doubt that Autolus Therapeutics plc ADR (AUTL) ticks all the boxes. - Sete News
Autolus Therapeutics plc ADR (AUTL) receives a Buy rating from Goldman - knoxdaily.com
AUTL’s valuation metrics: A comprehensive analysis - uspostnews.com
Market Resilience: Autolus Therapeutics plc ADR (AUTL) Finishes Weak at 1.33, Down -5.00 - DWinneX
Market Update: Goosehead Insurance Inc (GSHD) Sees Positive Movement, Closing at 99.54 - DWinneX
How Do Things Look For Autolus Therapeutics plc ADR (NASDAQ: AUTL) In The Short-Term? - Stocksregister
UK approves Autolus leukemia therapy with conditions By Investing.com - Investing.com India
For Autolus Therapeutics plc ADR [AUTL], Analyst sees a rise to $7.60. What next? - dbtnews.com
UK approves Autolus leukemia therapy with conditions - Investing.com
Autolus Therapeutics plc ADR [NASDAQ: AUTL] Sees Decrease in Stock Value - knoxdaily.com
Market cap of i-80 Gold Corp [IAUX] reaches 279.54M – now what? - dbtnews.com
Daiwa Securities lifts Bilibili Inc ADR [BILI] price estimate. Who else is bullish? - dbtnews.com
Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60 - DWinneX
It makes sense and dollars to buy Autolus Therapeutics plc ADR (AUTL) stock - Sete News
How does PROG Holdings Inc (PRG) change from a tortoise to a hare? - Sete News
Investors in cash trouble should check out BBB Foods Inc (TBBB) - Sete News
Take off with Energous Corp (WATT): Get ready for trading - Sete News
The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News
Tokio Marine Holdings, Inc. Sponsored ADR (OTCMKTS:TKOMY) Short Interest Update - Defense World
PSQ Holdings Inc (PSQH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India
Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa
Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India
Autolus reports progress in commercial launch and financials - Investing.com India
Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa
Autolus at Leerink’s Global Healthcare Conference: Strategic Moves in CAR T Therapy - Investing.com
10 Best UK Growth Stocks to Buy Now - Insider Monkey
Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex
It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):